About Cofactor Genomics
Cofactor Genomics is a private company based in San Francisco, California. It has reported $18,765,160 raised in three offerings on Form D since June 2017. Its chief executive is Jarret Glasscock.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Jul 20, 2023 | Aug 2, 2023 | $1,174,682of $2.0M target | 2 | $587K | EquityRule 506(b) | Form D ↗ |
| Dec 8, 2021 | Dec 16, 2021 | $6,906,712of $7.0M target | 9 | $767K | EquityRule 506(b) | Form D ↗ |
| Jun 14, 2017 | Jun 28, 2017 | $10,683,766of $15.1M target | 23 | $464K | EquityRule 506(b) | Form D ↗ |
| Total, three offerings | $18,765,160 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Cofactor Genomics's Form D filed Aug 2, 2023.
WH
William Hagstrom
Director
DM
David Messina
Executive officer
JK
John Kuelper
Executive officer and director
JG
Jarret Glasscock
Chief Executive Officer and director
MS
Mark Siegel
Director
Earlier filings also listed Jon Armstrong (director, last listed Dec 2021), Armen Vidian (director, last listed Dec 2021), Matthew Ocko (director, last listed Jun 2017) and Jarret Glassock (chief executive officer and director, last listed Jun 2017).